Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artelac Lipids is an ophthalmic lubricant formulated to relieve symptoms of chronic tear dysfunction and dry eye disease. It is designed to support all three layers of the tear film by providing hydration with sterile water, moisture retention with carbomer, and stabilization of the lipid layer using medium chain triglycerides. This combination helps reduce evaporation from the ocular surface and provides long-lasting relief for patients experiencing burning, gritty sensation, blurry vision, or excessive tearing due to dry eyes. The product is preservative-free in some presentations and suitable for individuals with persistent or severe dry eye symptoms caused by chronic conditions or medication use. Its mechanism of action involves supplementing both the aqueous and lipid components of the natural tear film to restore ocular surface homeostasis[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artelac Lipids.